181 related articles for article (PubMed ID: 10463586)
1. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.
Nakayama H; Ishimaru F; Avitahl N; Sezaki N; Fujii N; Nakase K; Ninomiya Y; Harashima A; Minowada J; Tsuchiyama J; Imajoh K; Tsubota T; Fukuda S; Sezaki T; Kojima K; Hara M; Takimoto H; Yorimitsu S; Takahashi I; Miyata A; Taniguchi S; Tokunaga Y; Gondo H; Niho Y; Harada M
Cancer Res; 1999 Aug; 59(16):3931-4. PubMed ID: 10463586
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia.
Nakase K; Ishimaru F; Avitahl N; Dansako H; Matsuo K; Fujii K; Sezaki N; Nakayama H; Yano T; Fukuda S; Imajoh K; Takeuchi M; Miyata A; Hara M; Yasukawa M; Takahashi I; Taguchi H; Matsue K; Nakao S; Niho Y; Takenaka K; Shinagawa K; Ikeda K; Niiya K; Harada M
Cancer Res; 2000 Aug; 60(15):4062-5. PubMed ID: 10945610
[TBL] [Abstract][Full Text] [Related]
3. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Sun L; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Mao C; Vassilev A; Reaman GH; Uckun FM
Clin Cancer Res; 1999 Aug; 5(8):2112-20. PubMed ID: 10473095
[TBL] [Abstract][Full Text] [Related]
4. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
[TBL] [Abstract][Full Text] [Related]
9. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
10. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.
Nagamachi A; Yamasaki N; Miyazaki K; Oda H; Miyazaki M; Honda Z; Kominami R; Inaba T; Honda H
Cancer Sci; 2009 Jul; 100(7):1219-26. PubMed ID: 19432895
[TBL] [Abstract][Full Text] [Related]
12. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV
Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.
Yamaguchi M; Yamamoto K; Miura O
Genes Chromosomes Cancer; 2003 Nov; 38(3):269-73. PubMed ID: 14506703
[TBL] [Abstract][Full Text] [Related]
14. Regulation of L-selectin expression by a dominant negative Ikaros protein.
Christopherson I; Piechoki M; Liu G; Ratner S; Galy A
J Leukoc Biol; 2001 Apr; 69(4):675-83. PubMed ID: 11310856
[TBL] [Abstract][Full Text] [Related]
15. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
16. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
Chen SJ; Wang Q; Tong JH; Xie WJ; Cao Q; Cai JR; Li XS; Wang ZY; Chen Z; Larsen CJ
Nouv Rev Fr Hematol (1978); 1991; 33(6):481-4. PubMed ID: 1818302
[TBL] [Abstract][Full Text] [Related]
17. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
18. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
[TBL] [Abstract][Full Text] [Related]
20. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
